Tilahun Mekdes, Shibabaw Agumas, Kiflie Amare, Bewket Gezahegn, Abate Ebba, Gelaw Baye
Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences (CMHS), The University of Gondar (UOG), P.O. box 196, Gondar, Ethiopia.
Department of Immunology and Molecular Biology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences (CMHS), The University of Gondar (UOG), P.O. box 196, Gondar, Ethiopia.
BMC Res Notes. 2019 Aug 16;12(1):515. doi: 10.1186/s13104-019-4548-x.
Immuno-compromised individuals with latent tuberculosis infection (LTBI) are at an increased risk for tuberculosis reactivation compared with the general population. The aim of this study was to determine the prevalence of latent tuberculosis infection among people living with human immunodeficiency virus (PLWH) and apparently healthy blood donors. Human Immunodeficiency Virus positive individuals and for the purpose of comparison apparently healthy blood donors were enrolled. Blood sample was collected and tested for LTBI using QuantiFeron-TB Gold In-Tube assay (QFT-GIT) and CD4+ T cell count was determined by using BD FACS count.
The overall prevalence of LTBI regardless of HIV status was 46%. The prevalence of LTBI among PLWH was 44% and that of blood donors 48%. ART naïve HIV positive patients were three times more likely to have LTBI than patients under ART treatment (P = 0.04). Data also showed statistically significant negative association between previous or current preventive INH therapy and LTBI among HIV positive cases (P = 0.005). The proportion of LTBI was slightly lower among HIV positive individuals than apparently healthy blood donors. Nevertheless, HIV positive individuals should be screened for LTBI and take INH prophylaxis.
与普通人群相比,潜伏性结核感染(LTBI)的免疫功能低下个体发生结核病复发的风险更高。本研究的目的是确定人类免疫缺陷病毒感染者(PLWH)和表面健康的献血者中潜伏性结核感染的患病率。招募了人类免疫缺陷病毒阳性个体以及作为对照的表面健康的献血者。采集血样,使用全血γ干扰素释放试验(QFT-GIT)检测LTBI,并使用BD FACS计数仪测定CD4 + T细胞计数。
无论HIV状态如何,LTBI的总体患病率为46%。PLWH中LTBI的患病率为44%,献血者为48%。未接受抗逆转录病毒治疗(ART)的HIV阳性患者发生LTBI的可能性是接受ART治疗患者的三倍(P = 0.04)。数据还显示,在HIV阳性病例中,既往或当前预防性使用异烟肼治疗与LTBI之间存在统计学上显著的负相关(P = 0.005)。HIV阳性个体中LTBI的比例略低于表面健康的献血者。尽管如此,仍应对HIV阳性个体进行LTBI筛查并采取异烟肼预防措施。